Cefepime is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Cefepime Hydrochloride.
Product ID | 0409-9735_86987a97-5bac-4103-862e-98ce0b434174 |
NDC | 0409-9735 |
Product Type | Human Prescription Drug |
Proprietary Name | Cefepime |
Generic Name | Cefepime |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-08-24 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA065441 |
Labeler Name | Hospira, Inc. |
Substance Name | CEFEPIME HYDROCHLORIDE |
Active Ingredient Strength | 2 g/1 |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-08-24 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0338-1301 | Cefepime | cefepime |
0409-9566 | Cefepime | Cefepime |
0409-9735 | Cefepime | Cefepime |
25021-121 | cefepime | cefepime hydrochloride |
25021-122 | cefepime | cefepime hydrochloride |
44567-130 | Cefepime | Cefepime |
44567-131 | Cefepime | Cefepime |
44567-240 | Cefepime | Cefepime |
44567-241 | Cefepime | Cefepime |
71288-008 | Cefepime | Cefepime |
71288-009 | Cefepime | Cefepime |
60505-6147 | Cefepime | Cefepime |
60505-6144 | Cefepime | Cefepime |
60505-6146 | Cefepime | Cefepime |
60505-6145 | Cefepime | Cefepime |
60505-6030 | Cefepime | Cefepime |
60505-6031 | Cefepime | Cefepime |
63323-340 | Cefepime | Cefepime |
63323-326 | Cefepime | Cefepime |
66794-210 | Cefepime | Cefepime |
66288-8100 | CEFEPIME | CEFEPIME |
67184-1003 | Cefepime | Cefepime |
67184-1004 | Cefepime | Cefepime |
66794-209 | Cefepime | Cefepime |
67184-1002 | Cefepime | Cefepime |
71288-021 | Cefepime | Cefepime |
71288-020 | Cefepime | Cefepime |
0409-0217 | MAXIPIME | Cefepime |
0409-0218 | MAXIPIME | Cefepime |
0409-0219 | MAXIPIME | Cefepime |
0409-0220 | MAXIPIME | Cefepime |